↓ Skip to main content

Cochrane Database of Systematic Reviews

Donepezil for mild cognitive impairment

Overview of attention for article published in Cochrane database of systematic reviews, July 2006
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (70th percentile)
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
2 X users
facebook
1 Facebook page
wikipedia
4 Wikipedia pages

Citations

dimensions_citation
143 Dimensions

Readers on

mendeley
224 Mendeley
Title
Donepezil for mild cognitive impairment
Published in
Cochrane database of systematic reviews, July 2006
DOI 10.1002/14651858.cd006104
Pubmed ID
Authors

Jacqueline Birks, Leon Flicker

Abstract

Problems with memory which do not meet the diagnostic criteria for dementia, usually called mild cognitive impairment (MCI), can be the first sign of an impending dementia, particularly Alzheimer's disease (AD). There is no consensus on a definition or diagnostic criteria for MCI, and MCI remains a vague term and those so described are a heterogeneous population, consisting of people who may rapidly progress to dementia but also of people with stable cognitive deficits and some who may actually improve. Treatment in the very earliest stages of AD may delay progression to AD. Donepezil (Aricept, E2020), a cholinesterase inhibitor, has been shown to benefit all severities of AD including mild and it would be reasonable to investigate its efficacy for those with MCI.

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 224 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 1 <1%
India 1 <1%
Sweden 1 <1%
Germany 1 <1%
Unknown 220 98%

Demographic breakdown

Readers by professional status Count As %
Researcher 31 14%
Student > Master 29 13%
Student > Bachelor 25 11%
Student > Ph. D. Student 19 8%
Student > Doctoral Student 14 6%
Other 52 23%
Unknown 54 24%
Readers by discipline Count As %
Medicine and Dentistry 54 24%
Psychology 23 10%
Neuroscience 14 6%
Agricultural and Biological Sciences 13 6%
Nursing and Health Professions 11 5%
Other 41 18%
Unknown 68 30%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 5. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 25 June 2022.
All research outputs
#6,959,369
of 25,457,297 outputs
Outputs from Cochrane database of systematic reviews
#8,078
of 11,499 outputs
Outputs of similar age
#27,203
of 90,872 outputs
Outputs of similar age from Cochrane database of systematic reviews
#45
of 74 outputs
Altmetric has tracked 25,457,297 research outputs across all sources so far. This one has received more attention than most of these and is in the 72nd percentile.
So far Altmetric has tracked 11,499 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 40.0. This one is in the 29th percentile – i.e., 29% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 90,872 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 70% of its contemporaries.
We're also able to compare this research output to 74 others from the same source and published within six weeks on either side of this one. This one is in the 39th percentile – i.e., 39% of its contemporaries scored the same or lower than it.